Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost/timolol in glaucoma or ocular hypertension
NCT00332540Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2001
- Primary completion
- Aug 2003
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3 trial of bimatoprost and timolol in ocular hypertension and Glaucoma, sponsored by Allergan. Primary endpoint: Intraocular Pressure. Started Aug 2001; status: completed.
02
Drugs
bimatoprosttimolol
03
Conditions
ocular hypertensionGlaucoma
Beyond the preview
Go deeper on NCT00332540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332540.